Testimonials

Trusted by Healthcare Professionals Worldwide

Cardiologists, imaging specialists, sonographers, and partner organizations on what fully automated AI echocardiography changes in real practice: speed, consistency, and earlier detection.

Read Testimonials See the Clinical Evidence

Video Interviews

In Their Own Words

Cardiologists on what fully automated AI echocardiography changes in their own practice, on camera and in measured results.

USA · Academic medical center

Us2.ai's platform already provides powerful automated measurements that support the detection of cardiac amyloidosis. But this new deep learning approach moves beyond standard measurement workflows by enabling fast, fully automated detection of amyloidosis from a single echo view. By simplifying image requirements while maintaining diagnostic accuracy, it has the potential to expand the role of echocardiography as an accessible, practical screening tool for earlier identification of patients with this life threatening yet treatable disease.

USA · Enterprise health system

What we found is that the AI workflow saves, on average, 10 to 12 minutes per study, for a total savings of about 33% per study, which was pretty remarkable.

Time saved per study: ~33%
Avg. minutes saved: 10–12

Japan · Academic medical center

AI provides a consistent 'gold standard' that can be uniformly applied to all examinations, significantly reducing variability between sonographers.

Netherlands · Community hospital

AI supports the process, but never replaces the medical judgement of the healthcare professional.

USA · Advanced cardiac imaging

Well, AI will not replace a physician, but a physician using AI will replace a physician not using AI!

Clinicians & Researchers

What Cardiologists and Sonographers Say

Physicians, imaging cardiologists, and sonographers on using fully automated AI echocardiography in day-to-day practice.

Cardiac amyloidosis remains a frequently under-diagnosed condition with significant prognostic implications. Us2.ai's AI-based pattern recognition model, applied to a standard apical four-chamber view, provides a validated and scalable solution to support early detection and enhance clinical decision-making within routine echocardiographic practice.

Marianna Fontana, MD, PhD

Professor of Cardiology and Honorary Consultant Cardiologist, National Amyloidosis Centre, University College London

From my personal experience, I have felt very fortunate to be able to use Us2.ai, a remarkable platform... I am truly amazed with its speed, overall accuracy and ease.

Becky Schwaegler, BS, RDMS, RDCS (AE,PE), FASE

Cardiac Sonographer Specialist / Lead

Shared with permission

I can't take my eyes off those images, and I can't believe I could get them with ZERO CLICKS!

Deepak Borde, MD, DNB, FCA, FTEE

Cardiac Anesthesiologist, United CIIGMA Hospital, India

Shared with permission

AI can significantly shorten diagnosis time from 35 to 40 minutes down to about 10 minutes. This innovation not only eases the workload for medical staff but also minimizes errors and reduces treatment costs.

Le Minh Khoi, MD

Associate Professor, Head of the Cardiovascular Imaging Unit, University of Medicine and Pharmacy Hospital, Ho Chi Minh City

Thanks to the AI analysis, we immediately receive objective measurements, allowing us to make decisions faster and more consistently. That is a win-win for both the patient and the healthcare provider.

Rudolf de Boer, MD, PhD

Head of the Cardiology Department, Erasmus MC

You should see it as a system that thinks alongside us and supports us in speeding up the analysis.

Gerrie Venema

Ultrasound Technician, Wilhelmina Ziekenhuis Assen

The US2 software could enable the use of echocardiography in screening or as a procedure at an accelerated pace and in a cost-effective manner.

Sreekanth Vemulapalli, MD

Associate Professor of Medicine, Duke University

Partners

What Our Partners Say

Device makers, AI platforms, and cardiovascular care networks on integrating Us2.ai into the care pathway.

We are proud to partner with Us2.ai to enhance and complement our comprehensive AI platform, tailoring it to cardiovascular needs, so that cardiologists and care teams can provide optimal care to more patients most efficiently.

Chris Mansi, MD, MBA

CEO, Viz.ai

Our partnership with Us2.ai allows our health system partners to further expand the clinical value of AI to cardiac care. Health systems cannot work with thousands of AI point solutions for each service line. Our aiOS allows health systems to think strategically about AI and build an end-to-end intelligence layer across the health system.

Elad Walach

CEO, Aidoc

Advara HeartCare

At Advara HeartCare we are committed to improving Australia's Heart Health. Whilst our clinical teams remain the focus (or at the heart) of our patients' care, partnering with US2Ai we are excited to investigate how AI can enhance our diagnostic capabilities and optimize the experience and clinical outcomes for our patients.

Daniel Cehic, MBBS, MBA, FICOS, FCSANZ, FRACP

CMO, Advara HeartCare

David O'Donnell, MBBS, FRACP, FCSANZ

CEO, Advara HeartCare

Us2.ai's capabilities align with Merge's mission to empower clinicians with smart and intuitive solutions…through this partnership, we're proud to continue paving the way for more consistent, precise, and efficient diagnostic workflows in cardiology.

Ashish Sant

Executive Vice President and General Manager, Merge

Echo images are the gold standard for non-invasive cardiac imaging, however the average time to complete an exam can take anywhere from 40 to 90 minutes, plus reporting time. AI has the ability to dramatically reduce this time burden, provide cardiologists with intelligent insights, and allow for more patients to get scanned. Fujifilm is thrilled to partner with Us2.ai to integrate their sophisticated AI with our cutting-edge LISENDO 880, providing cardiologists with exceptional, AI-driven automation analysis of the heart.

Hideyuki Honda

Vice President, Ultrasound Business Unit and Business Development, FUJIFILM Healthcare Americas Corporation

With cardiologists under incredible time pressure and an acute, worldwide shortage of sonographers, we believe that harnessing the power of AI can enable more efficient and effective cardiac care. We're excited to partner with Us2.ai and facilitate the availability of fast, reproducible echo analysis to global healthcare professionals via our whole-of-market AI platform.

Ben Panter

CEO, Blackford

We are pleased to work with Us2.ai to expand access to AI-enabled tools for echocardiography.

Dan Skyba

Sr. Managing Director, Ultrasound Business Unit, Canon Medical Systems USA

The clinicians have spoken. See it on your own studies.

See Automated AI Echo in Action

Book a demo to run fully automated measurements, disease detection, and reporting on your own echo studies, and see why clinicians and partners choose Us2.ai.